Martin F Kaiser (Martin Kaiser)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 37

Top Topics

Histone Deacetylase

Immune Response

Multiple Myeloma

Top Venues

British journal of haematology

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls. Research square (2023)
Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip J Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin F Kaiser, Richard S Houlston
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls. medRxiv : the preprint server for health sciences (2023)
Martin F Kaiser, Andrew Hall, Katrina Walker, Amy Sherborne, Ruth M De Tute, Nicola Newnham, Sadie Roberts, Emma Ingleson, Kristian M Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Richard S Houlston, Graham H Jackson, Curly T C M Morris, Guy Pratt, Roger G Owen, Mark T Drayson, Sarah R Brown, Matthew W Jenner
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sian E Faustini, Andrew Hall, Sarah R Brown, Sadie Roberts, Harriet Hill, Zania Stamataki, null null, Matthew W Jenner, Roger G Owen, Guy Pratt, Curly T C M Morris, Alex Richter, Mark T Drayson, Martin F Kaiser, Jennifer L J Heaney
Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial. British journal of haematology (2023)
Aikaterini Panopoulou, David A Cairns, Amy Elizabeth Holroyd, Isabel Nichols, Nikita Cray, Charlotte Pawlyn, Curly T C M Morris, Mark T Drayson, Kevin D Boyd, Faith E Davies, Matthew W Jenner, Gareth J Morgan, Roger G Owen, Richard S Houlston, Graham H Jackson, Martin F Kaiser
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood (2022)
Ruth M de Tute, Charlotte Pawlyn, David A Cairns, Faith E Davies, Tom Menzies, Andrew C Rawstron, John R Jones, Anna Hockaday, Rowena Henderson, Curly T C M Morris, Mark T Drayson, Matthew W Jenner, Martin F Kaiser, Walter M Gregory, Gareth J Morgan, Graham H Jackson, Roger G Owen
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Aikaterini Panopoulou, David A Cairns, Amy Elizabeth Holroyd, Isabel Nichols, Nikita Cray, Charlotte Pawlyn, Curly T C M Morris, Mark T Drayson, Kevin D Boyd, Faith E Davies, Matthew W Jenner, Gareth J Morgan, Roger G Owen, Richard S Houlston, Graham H Jackson, Martin F Kaiser
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamuraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Charles Agbuduwe, Gulnaz Iqbal, David A Cairns, Tom Menzies, Janet Dunn, Walter Gregory, Martin F Kaiser, Roger Owen, Charlotte Pawlyn, J Anthony Child, Faith Davies, Gareth J Morgan, Graham H Jackson, Mark T Drayson, Supratik Basu
Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials. Blood advances 6 (17) (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamaraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn A Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Kemal Samur, Caleb A Lareau, Gisli Hreinn Halldorsson, Gudmar Thorleifsson, Gudmundur L Norddahl, Kristbjorg Gunnarsdottir, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S Sperling, Martin F Kaiser, Kenneth C Anderson, Ingileif Jónsdóttir, Nikhil C Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G Sankaran, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature communications 13 (1) (2022)
Holger W Auner, Sarah R Brown, Katrina Walker, Jessica Kendall, Bryony Dawkins, David Meads, Gareth J Morgan, Martin F Kaiser, Mark Cook, Sadie Roberts, Christopher Parrish, Curly T C M Morris
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results. Blood cancer journal 12 (4) (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamuraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn A Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Kemal Samur, Caleb A Lareau, Gisli Hreinn Halldorsson, Gudmar Thorleifsson, Gudmundur L Norddahl, Kristbjorg Gunnarsdottir, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S Sperling, Martin F Kaiser, Kenneth C Anderson, Ingileif Jónsdóttir, Nikhil C Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G Sankaran, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature communications 13 (1) (2022)
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn A Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Kemal Samur, Caleb A Lareau, Gisli Hreinn Halldorsson, Gudmar Thorleifsson, Gudmundur L Norddahl, Kristbjorg Gunnarsdottir, Asta Försti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S Sperling, Martin F Kaiser, Kenneth C Anderson, Ingileif Jónsdóttir, Nikhil C Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G Sankaran, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk. Nature communications 13 (1) (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Ruth M de Tute, Anna Hockaday, Corinne Collett, John R Jones, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Alberto Rocci, John A Snowden, Matthew W Jenner, Gordon Cook, Nigel H Russell, Mark T Drayson, Walter Martin Gregory, Martin F Kaiser, Roger G Owen, Faith E Davies, Gareth J Morgan, null null
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLoS medicine 18 (1) (2021)
Hannah Victoria Giles, Mark A Cook, Mark Trehane Drayson, Gordon Cook, Nicola Jane Wright, Simon John North, Stephen Harding, David A Cairns, Anna Hockaday, Martin F Kaiser, Paul Moss, Faith E Davies, Gareth J Morgan, Graham Jackson, Guy Pratt
Redefining Non-measurable Multiple Myeloma Using Mass Spectrometry. Blood (2021)
Laura Duran-Lozano, Gudmar Thorleifsson, Aitzkoa Lopez de Lapuente Portilla, Abhishek Niroula, Molly Went, Malte Thodberg, Maroulio Pertesi, Ram Ajore, Caterina Cafaro, Pall I Olason, Lilja Stefansdottir, G Bragi Walters, Gisli Hreinn Halldorsson, Ingemar Turesson, Martin F Kaiser, Niels Weinhold, Niels Abildgaard, Niels Frost Andersen, Ulf-Henrik Mellqvist, Anders Waage, Annette Juul Vangsted, Unnur Thorsteinsdottir, Markus Hansson, Richard S Houlston, Thorunn Rafnar, Kari Stefansson, Björn Nilsson
Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk. Blood cancer journal 11 (11) (2021)
Benjamin T Diamond, Venkata Yellapantula, Even H Rustad, Kylee H Maclachlan, Marius Mayerhoefer, Martin F Kaiser, Gareth J Morgan, Ola Landgren, Francesco Maura
Positive selection as the unifying force for clonal evolution in multiple myeloma. Leukemia 35 (5) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Laura Duran-Lozano, Gudmar Thorleifsson, Aitzkoa Lopez de Lapuente Portilla, Abhishek Niroula, Molly Went, Malte Thodberg, Maroulio Pertesi, Ram Ajore, Caterina Cafaro, Pall I Olason, Lilja Stefansdottir, G Bragi Walters, Gisli Hreinn Halldorsson, Ingemar Turesson, Martin F Kaiser, Niels Weinhold, Niels Abildgaard, Niels Frost Andersen, Ulf-Henrik Mellqvist, Anders Waage, Annette Juul Vangsted, Unnur Thorsteinsdottir, Markus Hansson, Richard S Houlston, Thorunn Rafnar, Kari Stefansson, Björn Nilsson
Germline variants at SOHLH2 influence multiple myeloma risk. Blood cancer journal 11 (4) (2021)
Evangelos Terpos, Joseph Mikhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C Lee, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Karthik Ramasamy, Martin F Kaiser, Gordon Cook, Katja C Weisel, Caitlin L Costello, Jennifer Elliott, Antonio Palumbo, Saad Z Usmani
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood cancer journal 11 (2) (2021)
Phuc H Hoang, Alex J Cornish, Amy L Sherborne, Daniel Chubb, Scott Kimber, Graham Jackson, Gareth J Morgan, Curly T C M Morris, Ben Kinnersley, Martin F Kaiser, Richard S Houlston
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics. Blood cancer journal 10 (10) (2020)
Martin F Kaiser, James Croft, Paras Shah, Nadia Yousaf, Sanjay Popat
Durable response of multiple myeloma and non-small cell lung cancer with simultaneous, biologically targeted treatment. British journal of haematology 189 (1) (2020)
Sarah Anne Bird, Charlotte Pawlyn, Susanna Nallamilli, Priya Sriskandarajah, Martin F Kaiser, Kwee L Yong, Rakesh Popat, Neil Rabin, Kevin D Boyd
A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients. British journal of haematology 191 (5) (2020)
James Croft, Sidra Ellis, Amy L Sherborne, Kim Sharp, Amy Price, Matthew W Jenner, Mark T Drayson, Roger G Owen, Sally Chown, Jindriska Lindsay, Kamaraj Karunanithi, Hannah Hunter, Walter Martin Gregory, Faith E Davies, Gareth J Morgan, Curly T C M Morris, Lilit Atanesyan, Suvi Savola, David A Cairns, Graham Jackson, Richard S Houlston, Martin F Kaiser
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial. Leukemia 35 (7) (2020)
Ceri A Bygrave, Charlotte Pawlyn, Faith Davies, Zoe Craig, David A Cairns, Anna Hockaday, Matthew Jenner, Gordon Cook, Mark Drayson, Roger Owen, Walter Gregory, Gareth Morgan, Graham Jackson, Martin F Kaiser
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma. British journal of haematology 193 (3) (2020)
Vallari Shah, Amy L Sherborne, David C Johnson, Sidra Ellis, Amy Price, Farzana Chowdhury, Jack Kendall, Matthew W Jenner, Mark T Drayson, Roger G Owen, Walter M Gregory, Gareth J Morgan, Faith E Davies, Curly T C M Morris, David A Cairns, Richard S Houlston, Graham Jackson, Martin F Kaiser, null null
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients. Leukemia 34 (11) (2020)
Curly T C M Morris, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Martin F Kaiser, Matthew Jenner, Sarah Henshaw, Rachel Hall, Jonathan Sive, Simon Stern, Matthew Streetly, Ceri A Bygrave, Richard Soutar, Neil Rabin, Graham H Jackson, null null
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. British journal of haematology 190 (2) (2020)
Phuc H Hoang, Alex J Cornish, Daniel Chubb, Graham Jackson, Martin F Kaiser, Richard S Houlston
Impact of mitochondrial DNA mutations in multiple myeloma. Blood cancer journal 10 (5) (2020)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Alina Striha, Corinne Collett, Anna Waterhouse, John R Jones, Jamie Wilson, Craig Taylor, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew W Jenner, Curly T C M Morris, Nigel H Russell, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter M Gregory, Faith E Davies, Gareth J Morgan, null null
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial. British journal of haematology 192 (5) (2020)
Martin F Kaiser, Kevin Boyd, Dow-Mu Koh, Mihaela Rata, Matthew Blackledge, Christina Messiou
Improving real-world myeloma patient access to whole body MRI through "open-access" knowledge sharing: The UK experience. EJHaem 1 (1) (2020)
Vallari Shah, David C Johnson, Amy L Sherborne, Sidra Ellis, Frances M Aldridge, Julie Howard-Reeves, Farzana Begum, Amy Price, Jack Kendall, Laura Chiecchio, Suvi Savola, Matthew W Jenner, Mark T Drayson, Roger G Owen, Walter M Gregory, Gareth J Morgan, Faith E Davies, Richard S Houlston, Gordon Cook, David A Cairns, Graham Jackson, Martin F Kaiser, null null
Subclonal TP53 copy number is associated with prognosis in multiple myeloma. Blood 132 (23) (2018)
Eileen Mary Boyle, Cody Ashby, Christopher Paul Wardell, Dorota Rowczenio, Sajitha Sachchithanantham, Yan Wang, Sarah K Johnson, Michael A Bauer, Niels Weinhold, Martin F Kaiser, David C Johnson, John R Jones, Charlotte Pawlyn, Paula Proszek, Carolina Schinke, Thierry Facon, Charles Dumontet, Faith E Davies, Gareth J Morgan, Brian A Walker, Ashutosh D Wechalekar
The genomic landscape of plasma cells in systemic light chain amyloidosis. Blood 132 (26) (2018)
David C Johnson, Oleg Lenive, Jonathan Mitchell, Graham Jackson, Roger Owen, Mark Drayson, Gordon Cook, John R Jones, Charlotte Pawlyn, Faith E Davies, Brian A Walker, Christopher Wardell, Walter M Gregory, David Cairns, Gareth J Morgan, Richard S Houlston, Martin F Kaiser
Neutral tumor evolution in myeloma is associated with poor prognosis. Blood 130 (14) (2017)